iPSC-Derived Noradrenergic Neurons

iPSC-Derived Noradrenergic Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">iPSC-Derived Noradrenergic Neurons</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Stem Cell > iPSC > Noradrenergic</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>DBH, TH, PHOX2A</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>In Vitro</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>Parkinson's Disease, Depression</td>
</tr>
</table>

iPSC-Derived Noradrenergic Neurons

Overview

iPSC-Derived Noradrenergic Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">iPSC-Derived Noradrenergic Neurons</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Stem Cell > iPSC > Noradrenergic</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>DBH, TH, PHOX2A</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>In Vitro</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>Parkinson's Disease, Depression</td>
</tr>
</table>

iPSC-Derived Noradrenergic Neurons

Overview

iPSC-derived noradrenergic neurons are specialized neurons generated from induced pluripotent stem cells (iPSCs) that exhibit the molecular and functional properties of endogenous locus coeruleus noradrenergic neurons. These cells provide a critical in vitro model for studying Parkinson's disease (PD), depression, and norepinephrine-related neurodegeneration["@induced2023"].

<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:0000459](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000459) | noradrenergic cell |

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000459)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000459)
• [OBO Foundry (CL:0000459)](http://purl.obolibrary.org/obo/CL_0000459)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

| Database | ID | Name | Confidence |
|----------|----|------|------------|
| Cell Ontology | [CL:0000459](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000459) | noradrenergic cell | Medium |

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000459)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000459)
• [OBO Foundry (CL:0000459)](http://purl.obolibrary.org/obo/CL_0000459)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Differentiation Protocols

Overview

Differentiation of iPSCs into noradrenergic neurons follows a protocol that recapitulates the development of the locus coeruleus:

Key Growth Factors

• FGF8 (Fibroblast Growth Factor 8): Specifies noradrenergic lineage
• SHH (Sonic Hedgehog): Ventral patterning
• BDNF: Survival and maturation
• GDNF: Neuronal maintenance
• db-cAMP: Enhances norepinephrine synthesis

Molecular Characterization

Marker Expression

iPSC-derived noradrenergic neurons express canonical markers:

| Marker | Function | Detection Method |
|--------|----------|------------------|
| TH | Rate-limiting enzyme in catecholamine synthesis | Immunohistochemistry |
| DBH | Dopamine β-hydroxylase | qPCR, Western blot |
| PNMT | Phenylethanolamine N-methyltransferase | Immunohistochemistry |
| PHOX2A/B | Transcription factors | RNA-seq |
| NET (SLC6A2) | Norepinephrine transporter | Functional assay |

Transcriptomic Profile

Single-cell RNA sequencing shows that iPSC-derived noradrenergic neurons cluster with primary locus coeruleus neurons and express characteristic transcription factors including PHOX2A, PHOX2B, and FEV[@singlecell2024].

Electrophysiological Properties

Action Potential Firing

Mature iPSC-derived noradrenergic neurons exhibit:

• Resting Membrane Potential: -50 to -65 mV
• Action Potential Threshold: -35 to -45 mV
• Spike Amplitude: 70-90 mV
• Firing Pattern: Regular spiking with occasional burst firing
• Spontaneous Activity: 1-5 Hz firing rate

Noradrenergic Function

• Norepinephrine Release: Quantifiable via HPLC
• Receptor Expression: α1, α2, β-adrenergic receptors
• Autoreceptor Function: α2-mediated feedback inhibition

Disease Modeling Applications

Parkinson's Disease

iPSC-derived noradrenergic neurons from PD patients show:

• Reduced TH expression: 40-60% decrease[@noradrenergic2023]
• α-Synuclein aggregation: Lewy body-like inclusions
• Mitochondrial dysfunction: Complex I deficits
• Increased oxidative stress: ROS accumulation

Depression

Noradrenergic dysfunction is central to depression pathophysiology:

• NE transporter alterations: Reduced reuptake efficiency
• Receptor dysregulation: α2 autoreceptor hypersensitivity
• Cortical connectivity: Impaired prefrontal cortical modulation

Multiple System Atrophy

These neurons model:

• Autonomic dysfunction: Peripheral noradrenergic deficits
• Neurodegeneration: Progressive locus coeruleus loss

Drug Screening Applications

Therapeutic Targets

Screening Platforms

• Neuronal viability assays
• Norepinephrine release measurements
• cAMP signaling assays
• Calcium imaging for receptor function

Comparison to Locus Coeruleus Neurons

| Property | iPSC-Derived | Primary Human LC |
|----------|--------------|------------------|
| Availability | Unlimited | Very limited |
| Maturation | 6-8 weeks | N/A |
| Purity | 50-70% | Native |
| Functionality | Partial | Full |

Research Applications

In Vitro Disease Modeling

• Genetic risk factor validation
• Environmental toxin screening
• Age-related degeneration studies

Regenerative Medicine

• Cell replacement therapy potential
• Gene therapy vectors
• Bioengineered tissue constructs

Limitations

• Incomplete maturation: May not fully replicate aged neuron physiology
• Variability: Different iPSC lines show variable efficiency
• Species gaps: Human neurons differ from rodent models

See Also

• [Cell Types Index](/cell-types)
• [Technologies Index
• [Diseases Index](/content/diseases)
• [Locus Coeruleus Neurons](/cell-types/technologies-index](/content/technologies)
• [Parkinson's Disease](/diseases/parkinsons-disease)

Pathway Diagram

The following diagram shows the key molecular relationships involving iPSC-Derived Noradrenergic Neurons discovered through SciDEX knowledge graph analysis: